ArticleJournal of nanobiotechnology2021

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein.

Qizhong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.